Skip to main content
SpringerLink
Log in

Esophagitis

  • Chapter
  • First Online:
Acute Side Effects of Radiation Therapy

  • 2055 Accesses

Abstract

Radiation esophagitis is an acute dose-limiting toxicity associated with radiation treatment that decreases the patient’s compliance for treatment completion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Le Chevalier T, Arriagada R, Quoix E, Ruffle P, Martin M, Tarayre M et al (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83(6):417–423

    Article  PubMed  Google Scholar 

  2. Wei X, Liu HH, Tucker SL, Liao Z, Hu C, Mohan R, Cox JD, Komaki R (2006) Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66(1):100–107

    Article  PubMed  Google Scholar 

  3. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC et al (1990) A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323(14):940–945

    Article  CAS  PubMed  Google Scholar 

  4. Curran WJ, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S et al (2011) Sequential vs concurrent chemoradiation for stage III non-small cell lung cancer: randomized Phase III trial RTOG 9410. J Natl Cancer Inst 103(19):1452–1460

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Squier CA, Kremer MJ (2000) Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 29:7–15

    Google Scholar 

  6. Choy H, LaPorte K, Knill-Selby E, Mohr P, Shyr Y (eds) (1999) Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer. Semin Radiat Oncol 9(2 Suppl 1):90–96

    Google Scholar 

  7. Ozgen A, Hayran M, Kahraman F (2012) Mean esophageal radiation dose is predictive of the grade of acute esophagitis in lung cancer patients treated with concurrent radiotherapy and chemotherapy. J Radiat Res 53(6):916–922

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ball D, Bishop J, Smith J, Crennan E, O’Brien P, Davis S et al (1995) A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients. Int J Radiat Oncol Biol Phys 31(2):267–272

    Article  CAS  PubMed  Google Scholar 

  9. Bradley J, Deasy JO, Bentzen S, El Naqa I (2004) Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys 58(4):1106–1113

    Article  PubMed  Google Scholar 

  10. Choy H, Akerley W, Safran H, Graziano S, Chung C, Williams T et al (1998) Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol 16(10):3316–3322

    Article  CAS  PubMed  Google Scholar 

  11. Qiao W-B, Zhao Y-H, Zhao Y-B, Wang R-Z (2005) Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity. World J Gastroenterol 11(17):2626–2629

    Article  PubMed  PubMed Central  Google Scholar 

  12. Maguire PD, Sibley GS, Zhou S-M, Jamieson TA, Light KL, Antoine PA et al (1999) Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys 45(1):97–103

    Article  CAS  PubMed  Google Scholar 

  13. Singh AK, Lockett MA, Bradley JD (2003) Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 55(2):337–341

    Article  PubMed  Google Scholar 

  14. Byhardt R, Scott C, Sause W, Emami B, Komaki R, Fisher B et al (1998) Response, toxicity, failure patterns, and survival in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 42(3):469–478

    Article  CAS  PubMed  Google Scholar 

  15. Werner-Wasik M, Pequignot E, Leeper D, Hauck W, Curran W (2000) Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int J Radiat Oncol Biol Phys 48(3):689–696

    Article  CAS  PubMed  Google Scholar 

  16. Werner-Wasik M, Paulus R, Curran WJ, Byhardt R (2011) Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database. Clin Lung Cancer 12(4):245–251

    Article  CAS  PubMed  Google Scholar 

  17. Turrisi AT, Kim K, Blum R, Sause WT, Livingston RB, Komaki R et al (1999) Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340(4):265–271

    Article  CAS  PubMed  Google Scholar 

  18. Werner-Wasik M, Scott C, Graham ML, Smith C, Byhardt RW, Roach M et al (1999) Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients. Int J Radiat Oncol Biol Phys 44(2):327–331

    Article  CAS  PubMed  Google Scholar 

  19. Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M, Lebesque J (2005) Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 75(2):157–164

    Article  PubMed  Google Scholar 

  20. Leong SS, Tan EH, Fong KW, Wilder-Smith E, Ong YK, Tai BC et al (2003) Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small-cell lung cancer. J Clin Oncol 21(9):1767–1774

    Article  CAS  PubMed  Google Scholar 

  21. Maraz A, Furak J, Varga Z, Fodor E, Egyued Z, BorzĂ¡si E et al (2013) Acute oesophageal toxicity related to paclitaxel-based concurrent chemoradiotherapy for non-small cell lung cancer. Anticancer Res 33(4):1737–1741

    CAS  PubMed  Google Scholar 

  22. Bar-Ad V, Leiby B, Witek M, Xiao Y, Cui Y, Dai Y et al (2014) Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy. Am J Clin Oncol 37(5):433–437

    Article  CAS  PubMed  Google Scholar 

  23. Takeda K, Nemoto K, Saito H, Ogawa Y, Takai Y, Yamada S (2006) Predictive factors for acute esophageal toxicity in thoracic radiotherapy. Tohoku J Exp Med 208(4):299–306

    Article  PubMed  Google Scholar 

  24. Watkins JM, Wahlquist AE, Shirai K, Garrett-Mayer E, Aguero EG, Fortney JA et al (2009) Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 74(4):1108–1113

    Article  PubMed  Google Scholar 

  25. Zehentmayr F, Söhn M, Exeli A-K, Wurstbauer K, Tröller A, Deutschmann H et al (2015) Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid). Radiat Oncol 10(1):121

    Article  PubMed  PubMed Central  Google Scholar 

  26. Rodríguez N, Algara M, Foro P, Lacruz M, Reig A, Membrive I et al (2009) Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys 73(3):810–817

    Article  PubMed  Google Scholar 

  27. Zhang Z, Xu J, Zhou T, Yi Y, Li H, Sun H et al (2014) Risk factors of radiation-induced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapy. Radiat Oncol 9(1):54

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kuroda Y, Sekine I, Sumi M, Sekii S, Takahashi K, Inaba K et al (2013) Acute radiation esophagitis caused by high-dose involved field radiotherapy with concurrent cisplatin and vinorelbine for stage III non-small cell lung cancer. Technol Cancer Res Treat 12(4):333–339

    CAS  PubMed  Google Scholar 

  29. Palma DA, Senan S, Oberije C, Belderbos J, de Dios NR, Bradley JD et al (2013) Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 87(4):690–696

    Article  PubMed  Google Scholar 

  30. Patel AB, Edelman MJ, Kwok Y, Krasna MJ, Suntharalingam M (2004) Predictors of acute esophagitis in patients with non-small cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 60(4):1106–1112

    Article  PubMed  Google Scholar 

  31. Huang EX, Bradley JD, El Naqa I, Hope AJ, Lindsay PE, Bosch WR et al (2012) Modeling the risk of radiation-induced acute esophagitis for combined Washington University and RTOG trial 93-11 lung cancer patients. Int J Radiat Oncol Biol Phys 82(5):1674–1679

    Article  PubMed  Google Scholar 

  32. Gong B, Jiang N, Yan G, Wang S, Deng C, Wei S et al (2016) Predictors for severe acute esophagitis in lung cancer patients treated with chemoradiotherapy: a systematic review. Curr Med Res Opin 32(10):1701–1708

    Article  CAS  Google Scholar 

  33. Langer CJ, Movsas B, Hudes R, Schol J, Keenan E, Kilpatrick D et al (eds) (1997) Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001. Semin Oncol 24(4 Suppl 12):S12-89–S12-95

    Google Scholar 

  34. Yu Y, Guan H, Dong Y, Xing L, Li X (2016) Advances in dosimetry and biological predictors of radiation-induced esophagitis. Onco Targets Ther 9:597–603

    PubMed  PubMed Central  Google Scholar 

  35. Ellingrod VL, Schipper M, Stringer KA, Cai X, Hayman JA, Yu J et al (2013) Genetic variations in TGFβ1, tPA, and ACE and radiation-induced thoracic toxicities in patients with non-small-cell lung cancer. J Thorac Oncol 8(2):208–213

    Article  PubMed  PubMed Central  Google Scholar 

  36. Guerra JLL, Wei Q, Yuan X, Gomez D, Liu Z, Zhuang Y et al (2011) Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio (chemo) therapy. Radiother Oncol 101(2):271–277

    Article  CAS  Google Scholar 

  37. Hildebrandt MA, Komaki R, Liao Z, Gu J, Chang JY, Ye Y et al (2010) Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One 5(8):e12402

    Article  PubMed  PubMed Central  Google Scholar 

  38. Everitt S, Duffy M, Bressel M, McInnes B, Russell C, Sevitt T et al (2016) Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer. Radiat Oncol 11(1):20

    Article  PubMed  PubMed Central  Google Scholar 

  39. Tang C, Liao Z, Zhuang Y, Levy LB, Hung C, Li X et al (2014) Acute phase response before treatment predicts radiation esophagitis in non-small cell lung cancer. Radiother Oncol 110(3):493–498

    Article  PubMed  Google Scholar 

  40. Leigh BR, Lau DH (1998) Severe esophageal toxicity after thoracic radiation therapy for lung cancer associated with the human immunodeficiency virus: a case report and review of the literature. Am J Clin Oncol 21(5):479–481

    Article  CAS  PubMed  Google Scholar 

  41. Costleigh BJ, Miyamoto CT, Micaily B, Brady LW (1995) Heightened sensitivity of the esophagus to radiation in a patient with AIDS. Am J Gastroenterol 90(5):812–814

    CAS  PubMed  Google Scholar 

  42. Chapet O, Kong F-M, Lee JS, Hayman JA, Ten Haken RK (2005) Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 77(2):176–181

    Article  PubMed  Google Scholar 

  43. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341–1346

    Article  CAS  PubMed  Google Scholar 

  44. Nijkamp J, Rossi M, Lebesque J, Belderbos J, van den Heuvel M, Kwint M et al (2013) Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer. Radiother Oncol 106(1):118–123

    Article  PubMed  Google Scholar 

  45. Yuan ST, Brown RK, Zhao L, Ten Haken RK, Gross M, Cease KB et al (2014) Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy. Radiat Oncol 9(1):37

    Article  PubMed  PubMed Central  Google Scholar 

  46. Kwint M, Uyterlinde W, Nijkamp J, Chen C, de Bois J, Sonke J-J et al (2012) Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy. Int J Radiat Oncol Biol Phys 84(2):e223–e228

    Article  PubMed  Google Scholar 

  47. Kouvaris JR, Kouloulias VE, Vlahos LJ (2007) Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist 12(6):738–747

    Article  CAS  PubMed  Google Scholar 

  48. Antonadou D, Coliarakis N, Synodinou M, Athanassiou H, Kouveli A, Verigos C et al (2001) Randomized phase III trial of radiation treatment±amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys 51(4):915–922

    Article  CAS  PubMed  Google Scholar 

  49. Komaki R, Lee J, Kaplan B, Allen P, Kelly J, Liao Z et al (eds) (2002) Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results. Semin Radiat Oncol 12:46–49

    Google Scholar 

  50. Lawrence YR, Paulus R, Langer C, Werner-Wasik M, Buyyounouski MK, Komaki R et al (2013) The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801. Lung Cancer 80(3):298–305

    Article  PubMed  Google Scholar 

  51. Werner-Wasik M, Axelrod RS, Friedland DP, Hauck W, Rose LJ, Chapman AE et al (eds) (2002) Phase II: Trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy. Semin Radiat Oncol 12:34–39

    Google Scholar 

  52. Topkan E, Yavuz MN, Onal C, Yavuz AA (2009) Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters. Lung Cancer 63(3):393–399

    Article  PubMed  Google Scholar 

  53. McGinnis WL, Loprinzi CL, Buskirk SJ, Sloan JA, Drummond RG, Frank AR et al (1997) Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol 15(3):1239–1243

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Oncology, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences (SBMU), Shahid Madani Street, Tehran, Iran

    Ainaz Sourati & Ahmad Ameri

  2. Department of Radiotherapy and Oncology, Shohadaye Tajrish Educational Hospital Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran

    Mona Malekzadeh

Authors
  1. Ainaz Sourati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmad Ameri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mona Malekzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Sourati, A., Ameri, A., Malekzadeh, M. (2017). Esophagitis. In: Acute Side Effects of Radiation Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-55950-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-55950-6_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-55949-0

  • Online ISBN: 978-3-319-55950-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation